Your State:
Bookmark the new Broker Launchpad – guiding you to the right tool at the right time.
With 5 being the highest, how would you rate your experience on a scale of 1-5?
Nov 03, 2022
Emerging gene therapies show great promise for treatment of difficult rare conditions, but carry significant risk in terms of cost. Our Gene Therapy Solution works as a provision of our stop loss-policy to protect your administrative services only (ASO) National and Large Group clients from unknown financial risk while providing access to robust care management for individuals with rare and complex conditions. We continually update the Gene Therapy Solution web resource when new treatments are added.
You can also view a recording of our recent Gene Therapy webinar.
Mental and emotional health challenges are a top concern for employers. Timely access to care, specialty care providers, and personal preferences present unique challenges when connecting employees to the care they need when they need it. Please join us for a half-hour webinar on Tuesday, May 14...
Due to ongoing, national supply issues, starting May 15, 2024, and until the medications become readily available, members will not be able to fill the following GLP-1 drugs via CarelonRx Pharmacy home delivery: Mounjaro Trulicity Wegovy Saxenda We will notify you and your clients when th...